In addition, the drug decreased heart attacks and strokes by 20 percent compared to patients taking a placebo.
A new heart drug cuts cholesterol levels to once unthinkable lows, a treatment that doctors hope may prevent future heart attacks or stroke in high-risk patients, according to results from a highly anticipated study released Friday.
More than 27,000 heart patients in 49 countries were followed for two years in the largest study of its kind.
"While Repatha demonstrated sizeable reductions in future heart attacks and stroke, the trial didn`t show that people were less likely to die.
The drug lowered patients` cholesterol from a median LDL of 92 down to 30, something that`s usually almost impossible to do with medication.
0 comments:
Post a Comment